Contract for the supply of human papillomavrius vaccine
The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
Buyer
COMMERCIAL MEDICINES UNIT
Value
£0
Published
22 Dec 2016
Closes
19 Jan 2016
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
30 Jun 2016
Contract ends
30 Jun 2018
CPV classifications
33651000
General anti-infectives for systemic use and vaccines
Lots
Lot default Contract for the supply of human papillomavrius vaccine
£0
The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
Delivery: British Oversea Territories, Channel Islands, Europe, Guernsey, Isle of Man, Jersey
Documents
Unlock document linkAwarded contract notice on Contracts Finder
15 Dec 2015
Awarded contract notice on Contracts Finder
Award notice · Web page
ITO Documents along with OJEU notice
Not provided
ITO Documents along with OJEU notice
Application/x zip compressed · ZIP archive
AWARD DOCUMENTS
Not provided
AWARD DOCUMENTS
Application/x zip compressed · ZIP archive
ITO Documents along with OJEU notice
Not provided
ITO Documents along with OJEU notice
Application/x zip compressed · ZIP archive
AWARD DOCUMENTS_CM/PHV/12/5351/2
Not provided
AWARD DOCUMENTS_CM/PHV/12/5351/2
Award notice · ZIP archive
Contains public sector information licensed under the Open Government Licence v3.0.